Research Areas

Dr. Amit Singh
Microbial Pathogenesis

Our research activities are aimed at understanding the fundamental mechanisms involved in chronic human infections. We are focusing our efforts on dissecting how redox signaling controls virulence properties of Mycobacterium tuberculosis (Mtb) and human immunodeficiency virus (HIV).

Dr. Annapurna Vyakarnam
Immunilogy of HIV-Tuberculosis co-infection

My long-term research interests have focused on soluble factors / cytokines and their role in immunomodulation and immunity to infection, specifically defining CD4 T-cell subset function in the context of HIV pathogenesis. My laboratory uses a diverse set of methodologies covering immunology, cell biology and molecular biology and genomics to probe CD4 T-cell function at the cell and molecular level. Current areas of interest include, HIV-host interactions to define novel host factors in CD4 T cells that regulate HIV infection and to understand how CD4 T cell dysregulation in HIV infection can specifically contribute to the reactivation of latent TB in HIV-infected subjects. The laboratory hopes that basic knowledge gained from such studies can be translated to new biomarkers of disease and identify host pathways that may serve as novel therapeutic targets in HIV and TB infections.

Dr. Shashank Tripathi

Dr. Shashank Tripathi Joined Microbiology & Cell Biology Department of Indian Institute of Science as Assistant Professor on Jan 1st 2019. He was awarded Wellcome Trust India Alliance Intermediate fellowship in 2018. Earlier he worked as Research Assistant Professor (2017-2018) and as Post-Doctoral Researcher  (2012-2016) in Microbiology Department of Icahn School of Medicine at Mount Sinai in New York. There he worked in world renowned virologist Prof. Adolfo Garcia-Sastre’s lab, studying influenza A virus-host interactions at systems level and immune evasion and pathogenesis of Zika viruses. Dr. Tripathi did his PhD (2012) in supervision of Dr. Sunil Lal in the Virology Group of International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi in collaboration with Influenza Division, Centers for Disease Control, Atlanta.